Clinical Trial Technology Editorial

  1. Before Adding AI, Fix The Process 9/17/2026

    Regeneron’s Kaniel Cassady argues that “doing more with less” in clinical development should start with questioning existing processes, unnecessary data collection, and outdated workflows before turning to AI and other new technologies.

  2. How AI Will Reshape Study Start-Up 9/14/2026

    AI can help study start-up teams move from tracking delays to predicting risks—if human judgment, data quality, and governance stay central.

  3. What Will Life Science Orgs Do When The AI Bill Comes Through? 9/9/2026

    AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.

  4. What SIP Gets Right And Where It Still Falls Short 9/4/2026

    SIP users Sophie Haynes and Vicki Alvarez identify features that provide value but question whether the platform eliminates enough work to justify its setup demands, repetitive processes, and usability challenges.

  5. Turn AI Visibility Into Action: Build Explanation Layers For Different Stakeholders 9/4/2026

    AI visibility isn’t just about being found. Ross Jackson coaches sponsors on how to influence AI to provide clear stakeholder pathways for clinical trial involvement.

  6. Your Trial Shows Up In AI. Now What? 9/3/2026

    AI can explain your trial — but can it help patients act? Ross Jackson shares how sponsors can turn visibility into trust and next steps.

  7. The SIP Problem Is Bigger Than SIP 9/1/2026

    Sites continue to struggle with duplicated administrative work across too many sponsor and CRO systems. Current SIP users cite real frustrations with the platform, but their experiences also suggest the original goal of a shared, standardized site-information system remains highly relevant.

  8. Building SIP Was The Hard Part 8/26/2026

    Charlie Semenchuk and Jeff Ventimiglia helped turn the ambitious vision for the Shared Investigator Platform into reality. They look back at SIP’s technical challenges, competing stakeholder needs, site burden, and what the experience can still teach an industry wrestling with many of the same problems today.

  9. 4 Ways That AI And Point-Of-Care Diagnostics Are Redefining Clinical Trial Design And Operations 8/24/2026

    Discover how AI-enhanced point-of-care diagnostics are changing trial design and what ClinOps should do next.

  10. The Big Idea Behind The Creation Of SIP 8/20/2026

    Jackie Kent, Lisa Moneymaker, and Jeanette Teague were among the early architects of the Shared Investigator Platform (SIP). In part one of this four-part series, they discuss SIP’s ambitious origins, the challenges of getting competing sponsors to collaborate, and why broad adoption was critical to delivering on its promise of reducing site burden.